France
· Delayed Price · Currency is EUR EPA: ABLD Statistics
Total Valuation
ABL Diagnostics Société anonyme has a market cap or net worth of EUR 40.28 million. The enterprise value is 41.69 million.
| Market Cap | 40.28M |
| Enterprise Value | 41.69M |
Important Dates
The last earnings date was Tuesday, December 17, 2024.
| Earnings Date | Dec 17, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABL Diagnostics Société anonyme has 16.11 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 16.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 875,087 |
Valuation Ratios
The trailing PE ratio is 218.16.
| PE Ratio | 218.16 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 6.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 225.74 |
| EV / Sales | 6.71 |
| EV / EBITDA | 105.32 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.45.
| Current Ratio | 2.06 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 8.90 |
| Debt / FCF | n/a |
| Interest Coverage | -0.88 |
Financial Efficiency
Return on equity (ROE) is 2.72% and return on invested capital (ROIC) is -0.39%.
| Return on Equity (ROE) | 2.72% |
| Return on Assets (ROA) | -0.26% |
| Return on Capital (ROIC) | -0.39% |
| Revenue Per Employee | 365,247 |
| Profits Per Employee | 10,862 |
| Employee Count | 20 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 6.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.23% in the last 52 weeks. The beta is -0.22, so ABL Diagnostics Société anonyme's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | -74.23% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 2.90 |
| Relative Strength Index (RSI) | 10.20 |
| Average Volume (20 Days) | 72 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ABL Diagnostics Société anonyme had revenue of EUR 6.21 million and earned 184,656 in profits.
| Revenue | 6.21M |
| Gross Profit | 1.48M |
| Operating Income | -61,226 |
| Pretax Income | -443,141 |
| Net Income | 184,656 |
| EBITDA | 347,167 |
| EBIT | -61,226 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.69 million in cash and 3.09 million in debt, giving a net cash position of -1.40 million or -0.09 per share.
| Cash & Cash Equivalents | 1.69M |
| Total Debt | 3.09M |
| Net Cash | -1.40M |
| Net Cash Per Share | -0.09 |
| Equity (Book Value) | 6.85M |
| Book Value Per Share | n/a |
| Working Capital | 5.27M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 23.89%, with operating and profit margins of -0.99% and 2.97%.
| Gross Margin | 23.89% |
| Operating Margin | -0.99% |
| Pretax Margin | -7.14% |
| Profit Margin | 2.97% |
| EBITDA Margin | 5.59% |
| EBIT Margin | -0.99% |
| FCF Margin | n/a |
Dividends & Yields
ABL Diagnostics Société anonyme does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 8.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 8 |
Scores
ABL Diagnostics Société anonyme has an Altman Z-Score of 11.12.
| Altman Z-Score | 11.12 |
| Piotroski F-Score | n/a |